396 related articles for article (PubMed ID: 10877194)
1. Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats.
Rodriquez de Fonseca F; Navarro M; Alvarez E; Roncero I; Chowen JA; Maestre O; Gómez R; Muñoz RM; Eng J; Blázquez E
Metabolism; 2000 Jun; 49(6):709-17. PubMed ID: 10877194
[TBL] [Abstract][Full Text] [Related]
2. Central exendin-4 infusion reduces body weight without altering plasma leptin in (fa/fa) Zucker rats.
Al-Barazanji KA; Arch JR; Buckingham RE; Tadayyon M
Obes Res; 2000 Jul; 8(4):317-23. PubMed ID: 10933308
[TBL] [Abstract][Full Text] [Related]
3. Colocalization of glucagon-like peptide-1 (GLP-1) receptors, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake.
Navarro M; Rodriquez de Fonseca F; Alvarez E; Chowen JA; Zueco JA; Gomez R; Eng J; Blázquez E
J Neurochem; 1996 Nov; 67(5):1982-91. PubMed ID: 8863504
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of the brainstem preproglucagon system in the obese Zucker rat.
Vrang N; Larsen PJ; Jensen PB; Lykkegaard K; Artmann A; Larsen LK; Tang-Christensen M
Brain Res; 2008 Jan; 1187():116-24. PubMed ID: 18022140
[TBL] [Abstract][Full Text] [Related]
5. Effect of chronic central administration of glucagon-like peptide-1 (7-36) amide on food consumption and body weight in normal and obese rats.
Davis HR; Mullins DE; Pines JM; Hoos LM; France CF; Compton DS; Graziano MP; Sybertz EJ; Strader CD; Van Heek M
Obes Res; 1998 Mar; 6(2):147-56. PubMed ID: 9545022
[TBL] [Abstract][Full Text] [Related]
6. Separation of emetic and anorexic responses of exendin-4, a GLP-1 receptor agonist in Suncus murinus (house musk shrew).
Chan SW; Lin G; Yew DT; Yeung CK; Rudd JA
Neuropharmacology; 2013 Jul; 70():141-7. PubMed ID: 23357334
[TBL] [Abstract][Full Text] [Related]
7. Effects of exendin-4 alone and with peptide YY(3-36) on food intake and body weight in diet-induced obese rats.
Reidelberger RD; Haver AC; Apenteng BA; Anders KL; Steenson SM
Obesity (Silver Spring); 2011 Jan; 19(1):121-7. PubMed ID: 20559304
[TBL] [Abstract][Full Text] [Related]
8. S 23521 decreases food intake and body weight gain in diet-induced obese rats.
Claret M; Corominola H; Canals I; Nadal B; Chavanieu A; Pfeiffer B; Renard P; Gorostiaga C; Delagrange P; Grassy G; Gomis R
Obes Res; 2004 Oct; 12(10):1596-603. PubMed ID: 15536223
[TBL] [Abstract][Full Text] [Related]
9. Repeated intracerebroventricular administration of glucagon-like peptide-1-(7-36) amide or exendin-(9-39) alters body weight in the rat.
Meeran K; O'Shea D; Edwards CM; Turton MD; Heath MM; Gunn I; Abusnana S; Rossi M; Small CJ; Goldstone AP; Taylor GM; Sunter D; Steere J; Choi SJ; Ghatei MA; Bloom SR
Endocrinology; 1999 Jan; 140(1):244-50. PubMed ID: 9886831
[TBL] [Abstract][Full Text] [Related]
10. GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans.
van Bloemendaal L; IJzerman RG; Ten Kulve JS; Barkhof F; Konrad RJ; Drent ML; Veltman DJ; Diamant M
Diabetes; 2014 Dec; 63(12):4186-96. PubMed ID: 25071023
[TBL] [Abstract][Full Text] [Related]
11. Effect of glucagon-like peptide-1(7-36) and exendin-4 on the vascular reactivity in streptozotocin/nicotinamide-induced diabetic rats.
Ozyazgan S; Kutluata N; Afşar S; Ozdaş SB; Akkan AG
Pharmacology; 2005 Jun; 74(3):119-26. PubMed ID: 15746570
[TBL] [Abstract][Full Text] [Related]
12. Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4.
Kanoski SE; Fortin SM; Arnold M; Grill HJ; Hayes MR
Endocrinology; 2011 Aug; 152(8):3103-12. PubMed ID: 21693680
[TBL] [Abstract][Full Text] [Related]
13. Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1.
Cani PD; Neyrinck AM; Maton N; Delzenne NM
Obes Res; 2005 Jun; 13(6):1000-7. PubMed ID: 15976142
[TBL] [Abstract][Full Text] [Related]
14. Combined stimulation of glucagon-like peptide-1 receptor and inhibition of cannabinoid CB1 receptor act synergistically to reduce food intake and body weight in the rat.
Bojanowska E; Radziszewska E
J Physiol Pharmacol; 2011 Aug; 62(4):395-402. PubMed ID: 22100840
[TBL] [Abstract][Full Text] [Related]
15. Anorexigenic effects of GLP-1 and its analogues.
Gallwitz B
Handb Exp Pharmacol; 2012; (209):185-207. PubMed ID: 22249815
[TBL] [Abstract][Full Text] [Related]
16. Peripheral oxyntomodulin reduces food intake and body weight gain in rats.
Dakin CL; Small CJ; Batterham RL; Neary NM; Cohen MA; Patterson M; Ghatei MA; Bloom SR
Endocrinology; 2004 Jun; 145(6):2687-95. PubMed ID: 15001546
[TBL] [Abstract][Full Text] [Related]
17. Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats.
Larsen PJ; Fledelius C; Knudsen LB; Tang-Christensen M
Diabetes; 2001 Nov; 50(11):2530-9. PubMed ID: 11679431
[TBL] [Abstract][Full Text] [Related]
18. Chronic intracerebroventricular administration of recombinant CART(42-89) peptide inhibits and causes weight loss in lean and obese Zucker (fa/fa) rats.
Larsen PJ; Vrang N; Petersen PC; Kristensen P
Obes Res; 2000 Nov; 8(8):590-6. PubMed ID: 11156435
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of the long-acting GLP-1 receptor ligands, liraglutide and exendin-4, on food intake and body weight suppression in rats.
Hayes MR; Kanoski SE; Alhadeff AL; Grill HJ
Obesity (Silver Spring); 2011 Jul; 19(7):1342-9. PubMed ID: 21415845
[TBL] [Abstract][Full Text] [Related]
20. Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats.
Tang-Christensen M; Larsen PJ; Göke R; Fink-Jensen A; Jessop DS; Møller M; Sheikh SP
Am J Physiol; 1996 Oct; 271(4 Pt 2):R848-56. PubMed ID: 8897973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
